Literature DB >> 8001006

Cancer of unknown primary site.

C Muir1.   

Abstract

BACKGROUND: About 2% of more than 1 million cases of cancer diagnosed in residents of SEER areas for the 15-year period 1973-1987 were designated as being cancers of unknown primary site.
METHODS: The 26,050 histologically diagnosed cancers of unknown primary site were studied. The small groups of other and ill-defined sites within the respiratory and intrathoracic systems and other ill-defined sites (546 total) were included in this total.
RESULTS: Over the 15-year period, there has been a decrease in the number of these cancers for each race-sex group. There has been very little change over time in the distribution by histologic type. The most frequent diagnosis was adenocarcinoma (around 55%), with approximately equal numbers of epidermoid carcinoma and carcinoma, not otherwise specified (about 14%). Changes in the frequency of mucinous, small cell, and large cell carcinoma have been observed. Carcinoid tumors of unknown primary site increased substantially.
CONCLUSION: The decline in the numbers of cancers assigned to unknown primary site is to be welcomed.

Entities:  

Mesh:

Year:  1995        PMID: 8001006     DOI: 10.1002/1097-0142(19950101)75:1+<353::aid-cncr2820751317>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  RETROPERITONEAL CARCINOID (Case Report).

Authors:  Kailash Chand; N K Panicker
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  [Radiological diagnostics in CUP syndrome].

Authors:  P M Kazmierczak; K Nikolaou; A Rominger; A Graser; M F Reiser; C C Cyran
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.

Authors:  C S Karapetis; D Yip; K Virik; A Strickland; K Ryder; M Cowling; P G Harper
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

4.  Carcinoma of Unknown Primary - an Orphan Disease?

Authors:  Alwin Krämer; Gerdt Hübner; Andreas Schneeweiss; Gunnar Folprecht; Kai Neben
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

5.  Indolent metastatic squamous cell carcinoma of unknown primary in the intrathoracic lymph node: a case report and review of the literatures.

Authors:  Min Jin Kim; Sang Hyok Lim; Su Jung Han; Kang Hyug Choi; Sun Hyo Lee; Min Woo Park; HyeRan Kang; Ju Ock Na
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-01-29

6.  The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.

Authors:  Cristina R Ferrone; David T Ting; Mohammed Shahid; Ioannis T Konstantinidis; Francesco Sabbatino; Lipika Goyal; Travis Rice-Stitt; Ayesha Mubeen; Kshitij Arora; Nabeel Bardeesey; John Miura; T Clark Gamblin; Andrew X Zhu; Darrell Borger; Keith D Lillemoe; Miguel N Rivera; Vikram Deshpande
Journal:  Ann Surg Oncol       Date:  2014-12-18       Impact factor: 5.344

7.  [Pathologic and anatomic evidence of peritoneal metastases].

Authors:  I Tischoff; A Tannapfel
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

8.  Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.

Authors:  J Ponce Lorenzo; A Segura Huerta; R Díaz Beveridge; A Giménez Ortiz; F Aparisi Aparisi; T Fleitas Kanonnikoff; P Richart Aznar; H de la Cueva Sapiña; J Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

9.  Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.

Authors:  Sandro J Stoeckli; Katarzyna Mosna-Firlejczyk; Gerhard W Goerres
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-17       Impact factor: 9.236

10.  Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study.

Authors:  Kuo-Wei Chen; Chia-Jen Liu; Hsueh-Ju Lu; Cheng-Hwai Tzeng; Jin-Hwang Liu; Tzeon-Jye Chiou; Chueh-Chuan Yen; Wei-Shu Wang; Ta-Chung Chao; Hao-Wei Teng; Ming-Huang Chen; Chun-Yu Liu; Peter Mu-Hsin Chang; Muh-Hwa Yang
Journal:  BMC Res Notes       Date:  2012-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.